The hepatocyte-specific Hcfc1 knockout in Hcfc1hepKO/Y males models the development of terminal NASH characterized by increased steatosis, mitochondrial defects, increased inflammation and cell death, hepatocyte ballooning, fibrosis, progenitor cell activation, and metabolic dysfunction. This evidence concerns the gene HCFC1 and metabolic dysfunction-associated steatohepatitis.